We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Nanoplastics in Simulated Human Lung Fluids: Aggregation Kinetics, Theoretical Model Simulation, and Effects on Pulmonary Bacteria
Summary
Researchers studied how nanoplastics behave when they reach the lungs by testing them in simulated lung fluids. The nanoplastics clumped together more in fluids that mimic inflamed lungs compared to healthy lung fluids, and they were toxic to bacteria that naturally live in the lungs. This suggests that people with existing lung conditions may be especially vulnerable to inhaled nanoplastic exposure.
The widespread presence of nanoplastics poses serious threats to public health with inhalation emerging as a crucial exposure pathway. However, their behavior and toxicity in the pulmonary microenvironment are largely unknown. In this study, polystyrene nanoplastics (PSNPs) with different diameters and surface modifications were employed to investigate the aggregation kinetics, interaction mechanisms, and effects on pulmonary bacteria in different lung fluids. All PSNPs aggregated in inflammatory artificial lysosomal fluid (ALF), whereas bare- and carboxyl-modified PSNPs remained stable in healthy Gamble's solution (GS) and modified GS (MGS). Aggregation of PSNPs in ALF and GS followed the classical Derjaguin-Landau-Verwey-Overbeek theory, while steric hindrance and hydrogen bonding between PSNPs and the lung surfactant governed the aggregation in MGS. Furthermore, redundancy analysis indicated that the aggregation of PSNPs reduced oxidative stress and membrane damage to bacteria in lung fluids. Specifically, amino-modified PSNPs, which aggregated in GS, could induce sustained oxidative stress, damage the cell membrane of native pulmonary bacteria, and promote the release of pyoverdine from pathogenic bacteria up to 2.16 times. Moreover, the aging process significantly enhanced the toxicity of PSNPs on pulmonary bacteria. These findings enhance our understanding of the behavior and toxic effects of nanoplastics on humans.
Sign in to start a discussion.
More Papers Like This
Nanoplastics inSimulated Human Lung Fluids: AggregationKinetics, Theoretical Model Simulation, and Effects on Pulmonary Bacteria
Researchers studied how polystyrene nanoplastics of different sizes and surface charges behave in simulated lung fluids, finding that all particles aggregated in inflammatory fluid while charge-modified particles remained stable in healthy fluid. Aggregation followed classical colloidal theory and exposure to nanoplastics significantly inhibited the growth of key pulmonary bacteria.
Aggregation and deposition kinetics of polystyrene nanoplastics in lung fluids: Influence of particle property, fluid condition, and surfactant protein
Researchers investigated how tiny polystyrene nanoplastics behave after being inhaled into the lungs by simulating their interactions with lung fluids in the lab. They found that the particles rapidly clump together and settle out of acidic lung fluid much faster than neutral fluid, with particle size and surface charge playing key roles. The findings suggest that once inhaled, nanoplastics may accumulate in lung tissue rather than being easily cleared.
Molecular modeling of nanoplastic transformations in alveolar fluid and impacts on the lung surfactant film
Researchers used molecular dynamics simulations to model how inhaled nanoplastics interact with lung surfactant fluid at the air-water interface in the lungs. They found that lung surfactant molecules spontaneously coat nanoplastics to form coronas, and that some plastic types can be dissolved by lung surfactant, potentially increasing the bioavailability of toxic additives. The study suggests that nanoplastics could disrupt normal lung surfactant function, raising concerns about respiratory health effects.
Interaction of nanoplastics with simulated biological fluids and their effect on the biofilm formation
Researchers investigated how nanoplastics interact with simulated biological fluids including artificial saliva and lung fluids, finding that exposure altered particle properties and that nanoplastics promoted Staphylococcus aureus biofilm formation under biological conditions.
Microplastics exposed by respiratory tract and exacerbation of community-acquired pneumonia: The potential influences of respiratory microbiota and inflammatory factors
Researchers found that microplastics were present in the lungs of pneumonia patients, and that patients with severe pneumonia had higher levels of microplastics in their airways than those with milder cases. The microplastics appeared to worsen lung infections by disrupting the balance of airway bacteria and increasing inflammation. This study provides early evidence that inhaled microplastics may make respiratory infections more dangerous in humans.